The Peptide Craze Ground Truths Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet We have had multiple patients asking about the new GLP1 called Retatrutide. I have posted some good information below and will answer any questions you may have. Even the brand name of